Turkeys are among the most disease-susceptible birds in commercial poultry farming. Their physiology, selective breeding for rapid growth, and the close-quarters nature of modern production all make them vulnerable to a range of bacterial and viral infections. Managing turkey health is not just about treating sick birds – it requires a proactive strategy that combines vigilant monitoring, strict biosecurity, timely vaccination, and a clear understanding of the diseases most likely to strike your flock.
Table of Contents
- Why turkeys are particularly vulnerable to disease
- Erysipelas: the most serious bacterial threat
- How infection spreads
- Clinical signs and diagnosis
- Treatment and prevention
- Respiratory diseases: coryza and mycoplasma infections
- Infectious coryza
- Mycoplasma infections
- Viral diseases: turkey viral hepatitis and Newcastle disease
- Turkey viral hepatitis (TVH)
- Newcastle disease (Ranikhet disease)
- Biosecurity: the foundation of turkey health management
- Monitoring, record-keeping, and veterinary oversight
Why turkeys are particularly vulnerable to disease
Commercial turkey breeds have been selected over decades primarily for meat yield and growth rate, often at the cost of natural disease resistance. When birds are housed in close proximity, pathogens can spread rapidly through respiratory droplets, contaminated surfaces, litter, and even biting insects. This makes the confined production environment one of the greatest risk factors for disease outbreaks, and it is why understanding specific diseases – and how to prevent them – is central to successful turkey farming.
Erysipelas: the most serious bacterial threat
Erysipelas is caused by Erysipelothrix rhusiopathiae, a gram-positive, facultative anaerobic bacterium found widely in the environment. Among avian species, turkeys are most economically impacted by this disease, and it has also been recorded in ducks, laying hens, quail, and pheasants. The bacterium is remarkably persistent – it can survive in alkaline soil for years and is resistant to many common disinfectants, making environmental management critical.
How infection spreads
Infection typically enters through breaks in the skin from fighting or trauma, through mucous membranes during artificial insemination, or via cannibalism of infected carcasses. The red poultry mite (Dermanyssus gallinae) also acts as a vector and reservoir, potentially carrying the organism between successive flocks on the same premises. Under field conditions, turkey breeders are most frequently affected, and many reported outbreaks were associated with artificial insemination procedures.
Clinical signs and diagnosis
In its acute stage, erysipelas causes sudden death of infected birds, while some birds may show darkening of the skin or cyanosis in the head region and a sharp drop in egg production. Other signs include lethargy, swollen hocks, swollen snood, diarrhea, and in chronic cases, scabby skin lesions and endocarditis. Sudden death without prior clinical signs is common, which makes prompt post-mortem investigation essential. Presumptive diagnosis is based on gross lesions and impression smears from fresh spleen or liver, while definitive diagnosis requires aerobic culture or PCR assay.
Treatment and prevention
The antibiotic of choice for treating erysipelas is a short-acting penicillin such as potassium or sodium penicillin G. Tetracyclines in feed are also reported to be helpful in some cases. Importantly, the literature suggests that penicillins and aminopenicillins remain efficacious against E. rhusiopathiae, though any treatment must be guided by a veterinarian. For prevention in farms where erysipelas is endemic, vaccination is recommended at 16-20 weeks of age. Good biosecurity – including preventing contact with pigs, sheep, or previously contaminated land – also reduces risk significantly.
Respiratory diseases: coryza and mycoplasma infections
Respiratory diseases represent a major ongoing challenge in turkey flocks. They affect not just individual bird health but the overall performance of the flock, reducing growth rates, feed conversion efficiency, and in breeding birds, egg production. Two of the most significant are infectious coryza and Mycoplasma infections.
Infectious coryza
Infectious coryza, caused by Avibacterium paragallinarum, produces nasal discharge, facial swelling, and breathing difficulties. Mortality from coryza is usually low, but the infection can decrease egg production and increase the incidence and severity of concurrent diseases. The disease spreads primarily through direct bird-to-bird contact and also via contaminated feed and water. Recovered birds remain lifelong carriers and can shed the organism intermittently, making flock introductions a major risk. Prevention depends on maintaining good ventilation, avoiding overcrowding, and sourcing replacement birds from certified disease-free flocks.
Mycoplasma infections
Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are the two primary species affecting turkeys. In turkeys, MG infection commonly presents as swelling of one or both infraorbital sinuses (infectious sinusitis), along with nasal exudates. These infections are collectively referred to as Chronic Respiratory Disease (CRD). If untreated, Mycoplasma infection can persist from a few weeks to over 18 months, reducing egg production, hatchability, and carcass quality.
A critical feature of Mycoplasma is that it lacks a cell wall. This means antibiotics that target bacterial cell walls – such as penicillin – are ineffective. Instead, antibiotics like tylosin, tilmicosin, and tiamulin are used to reduce the mycoplasma load in the flock and relieve clinical symptoms, though they cannot fully eliminate the infection. There are no good vaccines available to control Mycoplasma in turkeys, and the F-strain vaccine used in chickens can be highly pathogenic for turkeys. The best control approach is sourcing birds from mycoplasma-free operations and testing new birds before flock introduction.
Viral diseases: turkey viral hepatitis and Newcastle disease
Viral infections present a distinct challenge because they generally cannot be treated with antibiotics. Control depends almost entirely on prevention – through vaccination, biosecurity, and minimizing stress in the flock.
Turkey viral hepatitis (TVH)
Turkey Viral Hepatitis is a highly infectious disease caused by a picornavirus (melegrivirus A) that primarily affects young poults. It is usually a subclinical condition that becomes clinically apparent under environmental stress or concurrent infection. The most common presentation is sudden death of apparently healthy birds; variable listlessness may be observed in affected flocks. In breeder flocks, it has been associated with reduced egg production, fertility, and hatchability. The virus is shed in feces and transmitted by both direct and indirect contact, and there is currently no specific treatment or preventive vaccine available. Management focuses on reducing stress, preventing concurrent infections, and maintaining scrupulously clean brooding environments.
Newcastle disease (Ranikhet disease)
Newcastle disease, known as Ranikhet disease in South Asia, is caused by avian paramyxovirus-1 (APMV-1) and is one of the most economically destructive viral diseases in poultry worldwide. The disease presents in three forms based on clinical severity: lentogenic (mild), mesogenic (moderate), and velogenic (severe). Signs in turkeys include respiratory distress, diarrhea, nervous symptoms such as twisted necks, and sudden death. Turkeys are generally less susceptible than chickens, showing lower mortality and less severe symptoms, but velogenic strains can still cause significant losses.
Vaccination is the primary line of defense. Live or inactivated lentogenic strains such as B1 and LaSota are available for turkeys and can be administered via drinking water or aerosol spray. A common vaccination schedule involves the Hitchner B1 vaccine at day-old, followed by a LaSota-type vaccine at 14 days, which may be repeated at 35-40 days if disease pressure is high. Serological monitoring of vaccinated breeding flocks is standard practice to confirm adequate immune response.
Biosecurity: the foundation of turkey health management
No vaccination program or treatment protocol can substitute for sound biosecurity. Biosecurity practices aim to prevent disease agents from entering the farm, spreading between sheds, carrying over between batches, or transmitting from breeding flocks to progeny via eggs. Three principles underpin effective biosecurity: isolation, traffic control, and sanitation.
Clean water free from organic and mineral contaminants is critical – it is a major vector for disease transmission in the production chain. All personnel entering poultry houses should use disinfectant footbaths, change clothing, and wash hands. Equipment such as feeders, waterers, and crates must be cleaned and disinfected between uses. After each flock, houses should remain sealed for a minimum of 14 days following complete cleaning and disinfection – a period known as “sanitary emptiness” – to allow residual pathogens to die off. This period may be extended following outbreaks of specific pathogens. Rodent and wild bird control are equally important, as both can introduce or amplify disease on the farm.
Monitoring, record-keeping, and veterinary oversight
Early detection of disease significantly improves treatment outcomes and limits flock losses. Farmers should maintain daily records of mortality, feed consumption, water intake, and behavioral changes. Any unusual increase in mortality or decline in production should trigger immediate veterinary consultation. Effective diagnosis of emerging turkey diseases requires close collaboration between investigative research and production veterinarians working in the field. Regular serological testing – particularly in breeding flocks – helps confirm vaccine protection levels and detect subclinical infections before they escalate. Drug treatments, when needed, should always be based on pathogen identification and sensitivity testing to avoid contributing to antimicrobial resistance.
What do you think? Given that some of the most damaging turkey diseases – like Turkey Viral Hepatitis – currently have no vaccines or specific treatments, how much responsibility should rest with farm management practices versus veterinary research in controlling these diseases? And with mycoplasma infections persisting for months despite treatment, what long-term flock management changes do you think could make the biggest difference for turkey farmers?
References
- https://www.mdpi.com/2306-7381/12/4/391
- https://www.msdvetmanual.com/poultry/erysipelas/erysipelas-in-poultry
- https://www.thepoultrysite.com/disease-guide/erysipelas
- https://pubmed.ncbi.nlm.nih.gov/33570103/
- https://he02.tci-thaijo.org/index.php/vis/article/view/260765
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3801280/
- https://ask.ifas.ufl.edu/publication/PS044
- https://extension.psu.edu/avian-mycoplasmosis
- https://www.farmhealthonline.com/US/disease-management/poultry-diseases/mycoplasmosis/
- https://www.msdvetmanual.com/poultry/turkey-viral-hepatitis/turkey-viral-hepatitis
- https://extension.psu.edu/newcastle-disease-avian-paramyxovirus-1
- https://www.thepoultrysite.com/disease-guide/newcastle-disease-paramyxovirus-1
- https://www.poultryhub.org/all-about-poultry/health-management/biosecurity-and-disease-prevention
- https://www.vaccinevalley.com/practical-procedures-for-disease-prevention-and-the-implementation-of-biosecurity-measures-in-poultry-facilities/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10907857/
Leave a Reply